Contract A207_PO-0442672-V3

The University of Virginia awarded contract A207_PO-0442672-V3 to Eurofins Genomics LLC on August 8, 2026, for the provision of synthetic oligonucleotide sequences. The contract, valued at thirty-one dollars, encompasses six distinct line items consisting of GAPDH (glyceraldehyde 3-phosphate dehydrogenase) gene primer sequences in salt-free formulation. The deliverables include three forward primer variants and three reverse primer variants, each designated as 25S (25 nucleotides in length) and salt-free preparations, with quantities of five units each per line item.

The synthetic oligonucleotides are designated for delivery to the University of Virginia as the buyer. These molecular biology reagents, which serve as research-grade primer sequences commonly utilized in polymerase chain reaction (PCR) applications, are typically employed in quantitative gene expression analysis. The minimal contract value reflects the limited scope of this procurement action, which appears to support academic research initiatives requiring standardized primer sets for GAPDH reference gene amplification in molecular biology experiments.